科济药业:全力推进通用型CAR-T产品开发 降低患者诊疗成本

新华财经
Nov 20, 2025

新华财经上海11月20日电(记者 魏雨田)11月20日,港股上市公司科济药业举办投资者交流活动,吸引了券商、基金等众多投资机构人士参与。作为专注于创新CAR-T细胞疗法(嵌合抗原受体T细胞免疫疗法)开发的生物制药企业,公司管理团队在活动中分享了CAR-T技术研发进展、核心产业布局及未来发展规划,为资本市场呈现了企业核心竞争力与行业发展前景。科济药业投资者交流活动现场(记者魏雨田 摄)聚焦CAR-T...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10